A clinical analysis of 14 cases of prostatic stromal tumor of uncertain malignant potential.
- Author:
Yi LIU
1
,
2
,
3
;
Zhi Jian LIU
1
,
2
,
3
;
Qi SHEN
1
,
2
,
3
;
Jing Yun WU
4
;
Yu FAN
1
,
2
,
3
;
De Run LI
1
,
2
,
3
;
Wei YU
1
,
2
,
3
;
Zhi Song HE
1
,
2
,
3
Author Information
1. Department of Urology, Peking University First Hospital
2. Institute of Urology, Peking University
3. National Urological Cancer Center, Beijing 100034, China.
4. Department of Radiology, Peking University First Hospital, Beijing 100034, China.
- Publication Type:Journal Article
- Keywords:
Pathology;
Prostatic neoplasms;
Stromal tumor of uncertain malignant potential
- MeSH:
Adult;
Aged;
Humans;
Magnetic Resonance Imaging;
Male;
Middle Aged;
Neoplasm Recurrence, Local;
Prostatic Neoplasms/surgery*;
Transurethral Resection of Prostate
- From:
Journal of Peking University(Health Sciences)
2020;52(4):621-624
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To investigate the clinical and pathologic characteristics, diagnosis, treatment, prognosis and survival of prostatic stromal tumor of uncertain malignant potential.
METHODS:Overall 14 patients with prostatic stromal tumor of uncertain malignant potential were treated from October 2008 to April 2020, the patient age ranged from 27 to 78 years (mean 54 years). The disease duration was 1 to 180 months (mean duration of 46 months). The clinical manifestations mainly included urinary obstructive symptoms and urethral irritating symptoms. The tumors were located in the peripheral zone or the transition zone. Digital rectum examination indicated prostatic tumor. Serum prostatic specific antigen level was always normal or elevated. Transrectal ultrasonography and magnetic resonance imaging indicated prostatic tumor. Magnetic resonance imaging in showed large, round, well-defined masses, which were diffusely heterogeneous signal on T2 weighted imaging. Following the administration of intravenous contrast medium, the lesion had diffuse and heterogeneous enhancement.
RESULTS:In the study, 3 cases underwent prostate biopsy, 2 cases underwent transurethral resection of the prostate, 9 cases underwent radical excision or transurethral resection of the prostate with definite diagnosis of pathologic features. Under the light microscope, the interstitial cells of stromal tumor of uncertain malignant potential were overgrowth and fusiform cells showed some degree of pleomorphism, nuclei with few mitotic figures, and necrosis was not often seen. Immunohistochemical staining showed that prostate specific antigen was negative, while vimentin was positive in the tumor tissue, CD34, progesterone receptor and smooth muscle actin were positive in the majority, and Ki67 positive index was 1%-20% (mean 6%). Twelve cases were followed-up, and the time of survival varied from 10 to 96 months (mean 65 months), two cases were lost to the follow-up, one case died of disease at the end of 10 months, nine cases were free of disease recurrence after surgery, two cases underwent more transurethral resection of the prostate due to local recurrence.
CONCLUSION:STUMP is a very rare tumor of the specialized prostatic stroma with an unpredictable clinical behavior. The clinical manifestations, transrectal ultrasonography and magnetic resonance imaging are valuable for the diagnosis of prostatic stromal tumor of uncertain malignant potential. Its definite diagnosis depends on pathological examination. Up to now, early surgery and combined therapy are effective treatments for prostatic stromal tumor of uncertain malignant potential.
